HDAC2 and chronic obstructive pulmonary disease: In addition, Malhotra et al. demonstrated HDAC2 S-nitrosylation and its functional relevance, which explains the inability to control chronic inflammation in chronic obstructive pulmonary disease (COPD) patients despite glucocorticoid therapy.